Regulatory

RxDC Reporting Will Bring Changes . . . Here’s What to Know Now

Jonas Leyrer, CEBS
 

Late last year, Congress passed the Consolidated Appropriations Act, 2021 (CAA), which contained a provision requiring health care plans to submit Prescription Drug Data Collection (RxDC) reports to CMS. RxDC was made retroactive for 2020 but its implementation was delayed for a […]

Inflation Reduction Act: 6 Health Care Provisions Plan Sponsors Should Know About

Julie Stich, CEBS
 

The U.S. House of Representatives is expected to consider a bill today that will likely reduce the cost of drugs for some Medicare recipients through a new cap on out-of-pocket costs and a provision that would allow the U.S. Department of Health […]

Unraveling Post-Dobbs Implications

The legal environment relating to abortion coverage has become quite complex following the U.S. Supreme Court decision in Dobbs v. Jackson Women’s Health Organization. Health plan sponsors should review their coverage of abortion services to ensure that their health plans reflect the […]

Post-Dobbs Employer Actions: New Survey Results

Over one in four employers is exploring the expansion of covered abortion services, according to a new report from the International Foundation of Employee Benefit Plans. The Post-Dobbs Employer Coverage: July 2022 Pulse Survey revealed current abortion coverage offerings and future considerations. […]

Everything Plan Sponsors Need to Know About SECURE Act 2.0

Amanda Wilke
 

On March 29, 2022, the House of Representatives passed the Securing a Strong Retirement Act of 2022 (HR 2954), otherwise known as SECURE Act 2.0, by a vote of 414-5. Secure Act 2.0 builds on the 2019 Setting Every Community Up for […]